InvestorsHub Logo
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Re: Investor100 post# 841

Wednesday, 09/07/2016 8:34:12 AM

Wednesday, September 07, 2016 8:34:12 AM

Post# of 13959
Immune Pharmaceuticals Receives $2 Million Investment in Common Stock at $0.50 per Share

Nice to see a bump in the PPS this morning!

https://finance.yahoo.com/news/immune-pharmaceuticals-receives-2-million-113000884.html

NEW YORK, Sept. 7, 2016 /PRNewswire/ -- Immune Pharmaceuticals Inc. (IMNP) ("Immune"), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer, announced today that it has entered into a stock purchase agreement with an existing stockholder for the sale of 4,000,000 shares of the Company's common stock at a fixed price of $0.50 per share, for gross proceeds of $2,000,000. There are no warrants, no restrictive covenants, and no restrictions on use of proceeds.

For full disclosure, please refer to the Form 8-K filed on September 7, 2016.

Investor 100

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.